SOURCE: Horizon Pharma plc

Horizon Pharma plc

June 19, 2015 07:00 ET

Timothy P. Walbert Receives EY Entrepreneur Of The Year® 2015 Midwest Award

DUBLIN, IRELAND--(Marketwired - Jun 19, 2015) - Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced that Chairman, President and Chief Executive Officer Timothy P. Walbert received the EY Entrepreneur Of The Year® 2015 Award in the Private Equity/Venture Capital category in the Midwest program.

The EY Entrepreneur Of The Year Award recognizes outstanding entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance and personal commitment to their businesses and communities. Walbert was selected by an independent panel of judges.

"I am honored and humbled by this award, which reinforces the incredible opportunities the Midwest offers to entrepreneurs," said Walbert. "This award represents the hard work and dedication of all my colleagues who on a daily basis continue to grow the company and help patients."

Walbert joined Horizon Pharma in 2008 as president and chief executive officer and has served as chairman of the company's board of directors since 2010. Under Walbert's leadership, Horizon Pharma has grown from a one product company to a seven product company; from one employee to more than 600 global employees and from a $150 million to a more than $5 billion market cap company. This period of growth included the acquisition of Vidara Therapeutics, which added ACTIMMUNE® (interferon gamma-1b) to the company's product portfolio. In May 2015, Horizon Pharma acquired Hyperion Therapeutics, which expanded Horizon's orphan business to three medicines with the addition of RAVICTI® and BUPHENYL®.

As a Midwest award winner, Walbert is now eligible for consideration for the Entrepreneur Of The Year 2015 national program, which will be announced on November 14, 2015.

About Horizon Pharma plc
Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets seven medicines through its orphan, primary care and specialty business units. Horizon's global headquarters are in Dublin, Ireland. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter or view careers on our LinkedIn page.

About EY Entrepreneur Of The Year®
EY Entrepreneur Of The Year is the world's most prestigious business award for entrepreneurs. The unique award makes a difference through the way it encourages entrepreneurial activity among those with potential and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global award of its kind, Entrepreneur Of The Year celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 145 cities in more than 60 countries.

Contact Information

  • Contact:

    Media:
    Geoff Curtis
    Group Vice President, Corporate Communications
    Email Contact